The chances of getting Long Covid were found to be half after the second dose of vaccination.
LONG COVID is a term that describes a variety of lingering illnesses that might interfere with a person’s ability to conduct daily tasks. However, according to a new study, taking both vaccines reduces the likelihood of developing persistent symptoms after an infection with COVID-19.
Since the pandemic began, up to two million people in the UK have been infected with Long Covid, with symptoms ranging from weariness to headaches. Although the disorder is still poorly understood, it has been compared to myalgic encephalomyelitis, a chronic fatigue syndrome with similar symptoms. According to a new study, a second dosage of the vaccination could halve the risk of having the condition.
After getting a second dose of the vaccine, the probability of developing Long COVID was decreased by nearly half, according to a study led by King’s College London researchers.
The study used data from more than two million users who used the UK ZOE COVID Symptom app to track their symptoms.
A total of 1,240,009 patients had gotten their first dose and 971,504 had received their second.
6,030 app users said they tested positive for COVID-19 at least 14 days after their first dose but before their second, and 2,370 said they tested positive at least seven days after their second dose.
A third jab will be delivered to those who are vulnerable for further protection.
According to the study, those who were fully vaccinated had a 73 percent lower risk of hospitalization and a lower burden of acute symptoms.
The symptoms of immunised patients who got the virus were comparable to those of unvaccinated adults, including loss of small, cough, fever, and headaches.
Sneezing was one of the more common symptoms reported by COVID-19 vaccine recipients.
Vaccine-induced symptoms were milder and less commonly reported in vaccinated patients.
In fact, in the first week of illness, they were half as likely to develop numerous symptoms.
“Vaccinations are dramatically reducing the likelihood of patients acquiring lengthy COVID in two ways,” stated Professor Tim Spector, lead investigator of the ZOE COVID app study.
“First, by halving the risks of any infections turning into Long COVID if they do occur, and secondly by reducing the risk of symptoms by 8 to 10 times.
“Whatever the duration of symptoms, we are observing that infections are substantially milder after two immunizations, indicating that vaccines are truly changing the disease for the better.
“We’re optimistic.” Brinkwire Summary News.